Tag Archives: Alimta

More Support for Novel Mesothelioma Drug Delivery System

Pharmaceutical researchers working on a way to make the most popular mesothelioma drug more effective have found more evidence that fat may be the answer. The team at Zagazig University in Egypt and Tokushima University in Japan have developed a fat-based coating for the antifolate drug pemetrexed (Alimta) that may help improve outcomes for patients. Pemetrexed is currently the only drug approved specifically to treat … Continue reading More Support for Novel Mesothelioma Drug Delivery System »

Clinical Trial May be Best Second-Line Approach for Mesothelioma

Doctor holding x-ray film

The best second-line treatment for mesothelioma patients who fail to respond to standard chemotherapy is probably to enroll in a clinical trial. The authors of a newly-published paper on the subject reached that conclusion after reviewing the results of 29 studies on potential second- or third-line mesothelioma treatments. Most patients who are diagnosed with mesothelioma, an aggressive malignancy associated with asbestos exposure, will undergo chemotherapy, … Continue reading Clinical Trial May be Best Second-Line Approach for Mesothelioma »